Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSSE Regulatory News (SSE)

Share Price Information for SSE (SSE)

Share Price is delayed by 15 minutes
Get Live Data
2,421.00    2.00 (0.08%)
Bid:
2,404.00
Ask:
2,406.00
Spread: 2.00 (0.083%)
Market Cap: £29.20b
SSE Live PriceLast checked at - London Stock Exchange

Intraday SSE Share Chart

Scrip Alternative

30 Aug 2022 15:43

RNS Number : 6400X
SSE PLC
30 August 2022
 

SSE PLC

 

FINAL DIVIDEND FOR THE YEAR ENDED 31 MARCH 2022

SCRIP ALTERNATIVE

SSE plc was notified on 29 August 2022 that a total of 26,101 shareholders have elected to receive the final dividend for the year ended 31 March 2022 of 60.2 pence per ordinary share in respect of 535,745,800 ordinary shares in the form of Scrip dividend. This will result in a reduction in final dividend cash funding of £322,518,972.

A total of 18,241,941 new ordinary shares, fully paid, will be issued on 22 September 2022, representing an increase of 1.71% on the issued share capital (excluding treasury shares) on the dividend record date of 29 July 2022. The relevant Scrip Reference Share Price was 1,768 pence per ordinary share.

In November 2021, as part of its fully funded Net Zero Acceleration Programme, SSE announced that the existing scrip dividend option for investors would be capped at 25% of investor uptake, through a share buy-back. Following notification of the final dividend elections SSE can confirm that overall scrip dividend take-up for the financial year ended 31 March 2022 was 38.33%. SSE therefore intends to initiate a share buy-back, in the period following the final dividend payment for the year ended 31 March 2022, in accordance with the authority granted by shareholders at SSE's Annual General Meeting on 21 July 2022 and Chapter 12 of the Listing Rules. The number of ordinary shares to be purchased will not exceed 6,904,083 ordinary shares, and the maximum pecuniary amount allocated to the Scrip buy-back is £125,000,000. SSE intends to complete this process by 31 March 2023.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVFLFSSTLIIVIF
Date   Source Headline
11th Jun 20254:15 pmRNSDirector/PDMR Shareholding
9th Jun 20252:28 pmRNSDirector/PDMR Shareholding
2nd Jun 20257:00 amRNSTotal Voting Rights
21st May 20257:00 amRNSPreliminary Results for the year ended 31 March 25
2nd May 20251:02 pmRNSDirector/PDMR Shareholding
1st May 20257:00 amRNSTotal Voting Rights
9th Apr 20251:40 pmRNSDirector/PDMR Shareholding
9th Apr 20259:45 amRNSDirector/PDMR Shareholding
2nd Apr 20257:00 amRNSNOTIFICATION OF CLOSED PERIOD
1st Apr 20257:00 amRNSTotal Voting Rights
28th Mar 20257:00 amRNSSSE ANNOUNCES MARTIN PIBWORTH AS CHIEF EXECUTIVE
11th Mar 20254:54 pmRNSSSE PLC ISSUES NEW €600m GREEN BOND
7th Mar 20252:09 pmRNSDirector/PDMR Shareholding
5th Mar 20254:57 pmRNSDirector/PDMR Shareholding
3rd Mar 20257:00 amRNSTotal Voting Rights
28th Feb 20254:28 pmRNSDirector/PDMR Shareholding
28th Feb 20251:47 pmRNSBlock Listing Six Monthly Return
20th Feb 20259:42 amRNSAdditional Listing
7th Feb 202512:45 pmRNSDirector/PDMR Shareholding
6th Feb 202511:08 amRNSSCRIP Alternative
5th Feb 20257:00 amRNSQ3 Trading Statement
3rd Feb 20257:00 amRNSTotal Voting Rights
9th Jan 202510:36 amRNSSCRIP Reference Price
8th Jan 20254:03 pmRNSHolding(s) in Company
7th Jan 20254:44 pmRNSDirector/PDMR Shareholding
7th Jan 20252:26 pmRNSHolding(s) in Company
2nd Jan 20257:00 amRNSTotal Voting Rights
31st Dec 20248:41 amRNSHolding(s) in Company
30th Dec 20245:04 pmRNSReplacement - Cancellation of announcement
30th Dec 20248:50 amRNSHolding(s) in Company
23rd Dec 20245:05 pmRNSHolding(s) in Company
23rd Dec 20243:47 pmRNSDirector/PDMR Shareholding
18th Dec 202412:14 pmRNSHolding(s) in Company
17th Dec 20241:07 pmRNSHolding(s) in Company
16th Dec 20244:30 pmRNSHolding(s) in Company
16th Dec 202410:30 amRNSHolding(s) in Company
10th Dec 20243:09 pmRNSDirector/PDMR Shareholding
10th Dec 20248:30 amRNSSSEN TRANSMISSION PUBLISHES RIIO-T3 BUSINESS PLAN
2nd Dec 20247:00 amRNSTotal Voting Rights
13th Nov 20247:00 amRNSChief Executive Succession
13th Nov 20247:00 amRNSHalf-year Report
8th Nov 20244:09 pmRNSDirector/PDMR Shareholding
1st Nov 20247:00 amRNSDirectorate Change
1st Nov 20247:00 amRNSTotal Voting Rights
24th Oct 20242:06 pmRNSNew Sustainability Linked Credit Facilities
17th Oct 20247:00 amRNSTransaction in Own Shares & Completion of Buyback
16th Oct 20247:00 amRNSTransaction in Own Shares
15th Oct 20247:00 amRNSTransaction in Own Shares
14th Oct 20247:00 amRNSTransaction in Own Shares
11th Oct 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.